Multiple Sclerosis Clinical Trial
— AIMOfficial title:
Evaluation of an Online Course Designed to Support the Adoption of Healthier Diet and Self-Care Routines in Multiple Sclerosis Patients
The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, and post acute sequela of covid
Status | Recruiting |
Enrollment | 80 |
Est. completion date | December 1, 2026 |
Est. primary completion date | December 1, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility | Inclusion Criteria: - self-reported multiple sclerosis - self-reported clinically isolated syndrome OR self-reported post-acute sequelae of COVID (PASC), also known as long COVID, with a confirmed laboratory test of COVID-19 infection, persisting fatigue and neuropsychiatric symptoms for longer than 6 months after confirmation of COVID diagnosis, OR self-reported diagnosis of fibromyalgia as documented by their treating specialist or primary care provider, Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
United States | Univeristy of Iowa | Iowa City | Iowa |
Lead Sponsor | Collaborator |
---|---|
Terry L. Wahls |
United States,
Bisht B, Darling WG, Grossmann RE, Shivapour ET, Lutgendorf SK, Snetselaar LG, Hall MJ, Zimmerman MB, Wahls TL. A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue. J Altern Complement Med. 2014 May;20(5):347-55. doi: 10.1089/acm.2013.0188. Epub 2014 Jan 29. — View Citation
Bisht B, Darling WG, White EC, White KA, Shivapour ET, Zimmerman MB, Wahls TL. Effects of a multimodal intervention on gait and balance of subjects with progressive multiple sclerosis: a prospective longitudinal pilot study. Degener Neurol Neuromuscul Dis. 2017 Jun 26;7:79-93. doi: 10.2147/DNND.S128872. eCollection 2017. — View Citation
Chenard CA, Rubenstein LM, Snetselaar LG, Wahls TL. Nutrient Composition Comparison between a Modified Paleolithic Diet for Multiple Sclerosis and the Recommended Healthy U.S.-Style Eating Pattern. Nutrients. 2019 Mar 1;11(3):537. doi: 10.3390/nu11030537. — View Citation
Irish AK, Erickson CM, Wahls TL, Snetselaar LG, Darling WG. Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study. Degener Neurol Neuromuscul Dis. 2017 Jan 4;7:1-18. doi: 10.2147/DNND.S116949. eCollection 2017. — View Citation
Lee JE, Titcomb TJ, Bisht B, Rubenstein LM, Louison R, Wahls TL. A Modified MCT-Based Ketogenic Diet Increases Plasma beta-Hydroxybutyrate but Has Less Effect on Fatigue and Quality of Life in People with Multiple Sclerosis Compared to a Modified Paleolithic Diet: A Waitlist-Controlled, Randomized Pilot Study. J Am Coll Nutr. 2021 Jan;40(1):13-25. doi: 10.1080/07315724.2020.1734988. Epub 2020 Mar 26. — View Citation
Titcomb TJ, Bisht B, Moore DD 3rd, Chhonker YS, Murry DJ, Snetselaar LG, Wahls TL. Eating Pattern and Nutritional Risks among People with Multiple Sclerosis Following a Modified Paleolithic Diet. Nutrients. 2020 Jun 20;12(6):1844. doi: 10.3390/nu12061844. — View Citation
Wahls T, Scott MO, Alshare Z, Rubenstein L, Darling W, Carr L, Smith K, Chenard CA, LaRocca N, Snetselaar L. Dietary approaches to treat MS-related fatigue: comparing the modified Paleolithic (Wahls Elimination) and low saturated fat (Swank) diets on perceived fatigue in persons with relapsing-remitting multiple sclerosis: study protocol for a randomized controlled trial. Trials. 2018 Jun 4;19(1):309. doi: 10.1186/s13063-018-2680-x. — View Citation
Wahls TL, Chenard CA, Snetselaar LG. Review of Two Popular Eating Plans within the Multiple Sclerosis Community: Low Saturated Fat and Modified Paleolithic. Nutrients. 2019 Feb 7;11(2):352. doi: 10.3390/nu11020352. — View Citation
Wahls TL, Titcomb TJ, Bisht B, Eyck PT, Rubenstein LM, Carr LJ, Darling WG, Hoth KF, Kamholz J, Snetselaar LG. Impact of the Swank and Wahls elimination dietary interventions on fatigue and quality of life in relapsing-remitting multiple sclerosis: The WAVES randomized parallel-arm clinical trial. Mult Scler J Exp Transl Clin. 2021 Jul 31;7(3):20552173211035399. doi: 10.1177/20552173211035399. eCollection 2021 Jul-Sep. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Multiple Sclerosis 54 Quality of Life Mental Health (MS 54 QoL MH) | Change in (MS 54 QoL MH) survey questions mean scores, range 0-100, higher number is better. | baseline to 3 months | |
Primary | Multiple Sclerosis 54 Quality of Life Mental Health (MS 54 QoL MH) | Change in (MS 54 QoL MH) survey questions mean scores, range 0-100, higher number is better. | baseline to 6months | |
Primary | Multiple Sclerosis 54 Quality of Life Physical Health (MS 54 QoL PH) | Change in (MS 54 QoL PH) survey questions mean scores, range 0-100, higher number is better. | baseline to 3 months | |
Primary | Multiple Sclerosis 54 Quality of Life Physical Health (MS 54 QoL PH) | Change in (MS 54 QoL PH) survey questions mean scores, range 0-100, higher number is better. | baseline to 6 months | |
Primary | Short form 36 (SF 36) | Change in (SF 36) survey questions mean scores, range 0-100, higher number is better. | baseline to 3 months | |
Primary | Short form 36 (SF 36) | Change in (SF 36) survey questions mean scores, range 0-100, higher number is better. | baseline to 6 months | |
Secondary | Modified Fatigue Impact Scale | Change in MFIS survey questions, scores range from 0-84, lower score is better. | baseline to 3 months | |
Secondary | Modified Fatigue Impact Scale | Change in MFIS survey questions, scores range from 0-84, lower score is better. | baseline to 6 months | |
Secondary | vegetable and fruit intake | Change in number of servings of vegetables consumed per day, servings range from 0 to 9 or more | baseline to 3 months | |
Secondary | vegetable and fruit intake | Change in number of servings of vegetables consumed per day, servings range from 0 to 9 or more | baseline to 6 months | |
Secondary | added sugar intake | change in the grams of added sugar consumed each day, grams range from 0 to 100 | baseline to 3 months | |
Secondary | added sugar intake | change in the grams of added sugar consumed each day, grams range from 0 to 100 | baseline to 6 months | |
Secondary | calcium intake | change in calcium intake, range 0 to 2000 mg | baseline to 3 months | |
Secondary | calcium intake | change in calcium intake, range 0 to 2000 mg | baseline to 6 months | |
Secondary | Servings of whole grains consumed | change in number of servings of whole grains consumed, range 0 to 6 or more servings | baseline to 3 months | |
Secondary | Servings of whole grains consumed | change in number of servings of whole grains consumed, range 0 to 6 or more servings | baseline to 6 months | |
Secondary | Fibromyalgia Impact Questionnaire Revised | Pain Rating (0-10 Low to High Scale) with higher score indicating greater impact | baseline to 3 months | |
Secondary | Fibromyalgia Impact Questionnaire Revised | Pain Rating (0-10 Low to High Scale)15 items with higher score indicating greater impact | baseline to 6 months | |
Secondary | Brief Pain Inventory | Interference (0-10 Low to High Scale) 15 items with higher score indicating greater intensity | baseline to 3 months | |
Secondary | Brief Pain Inventory | Range 0-10( Low to High Scale) with higher score indicating greater pain intensity | baseline to 6 months | |
Secondary | FM Disease activity (FIQR) | 0-100( Low to High Scale)21 items used to evaluate function, overall impact, and symptoms in patients with fibromyalgia. | baseline to 3 months | |
Secondary | FM Disease activity (FIQR) | 0-100 (Low to High Scale)21 items used to evaluate function, overall impact, and symptoms in patients with fibromyalgia. High score indicating more severe symptoms. | baseline to 6 months | |
Secondary | Pain scale | 0-10 (low to high) 13 items used to evaluate feelings about pain. | baseline to 3 months | |
Secondary | Pain catastrophizing scale | 052 (low to high) 13 items used to evaluate feelings about pain. Higher scores indicating more severe feelings about pain related problems | baseline to 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|